Aveanna Healthcare director-linked entities sell $192.6m in stock

Paul R. Vigano, director of Aveanna Healthcare Holdings, Inc., sold a substantial $192.6 million worth of company stock across multiple transactions on August 20 and 21, 2026. The sold shares were from various entities connected to Vigano, as part of underwritten secondary offerings. Following the initial sale, the stock price surged to $13.70, marking a 19% increase from its sale price of $11.50, and is currently trading near its 52-week high of $13.98.

Analysts have deemed the stock overvalued relative to its Fair Value. Among the sellers were J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings, LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II, LLC, all executing sales at $11.5 per share. The subsequent sale by PSA Healthcare Investment Holding LLC on August 21, 2026, totaled $25,875,000, continuing the stock's momentum.

Vigano's indirect beneficial ownership through various entities like Equity Partners VII, Project Iliad, and Capital Partners cannot be overlooked despite his disclaimers. Since the stock's impressive gains, the company's strong Q2 2026 revenue of $670.5 million, exceeding forecasts, has led to a raised full-year outlook. This has resulted in price targets being raised by firms like Raymond James and RBC Capital, signaling positive market sentiment towards Aveanna Healthcare.